332 related articles for article (PubMed ID: 35582219)
1. Nanotechnological approaches for counteracting multidrug resistance in cancer.
Martinelli C; Biglietti M
Cancer Drug Resist; 2020; 3(4):1003-1020. PubMed ID: 35582219
[TBL] [Abstract][Full Text] [Related]
2. Nanodelivery systems: An efficient and target-specific approach for drug-resistant cancers.
Ashique S; Garg A; Hussain A; Farid A; Kumar P; Taghizadeh-Hesary F
Cancer Med; 2023 Sep; 12(18):18797-18825. PubMed ID: 37668041
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.
Tekchandani P; Kurmi BD; Paliwal SR
Mini Rev Med Chem; 2017; 17(18):1793-1810. PubMed ID: 26891930
[TBL] [Abstract][Full Text] [Related]
5. The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy.
Liu S; Khan AR; Yang X; Dong B; Ji J; Zhai G
J Control Release; 2021 Jul; 335():1-20. PubMed ID: 33991600
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance.
Wei X; Song M; Li W; Huang J; Yang G; Wang Y
Theranostics; 2021; 11(13):6334-6354. PubMed ID: 33995661
[TBL] [Abstract][Full Text] [Related]
7. Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnology.
Choudhury H; Pandey M; Yin TH; Kaur T; Jia GW; Tan SQL; Weijie H; Yang EKS; Keat CG; Bhattamishra SK; Kesharwani P; Md S; Molugulu N; Pichika MR; Gorain B
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():596-613. PubMed ID: 31029353
[TBL] [Abstract][Full Text] [Related]
8. Innovative nanochemotherapy for overcoming cancer multidrug resistance.
Tan H; Zhang M; Wang Y; Timashev P; Zhang Y; Zhang S; Liang XJ; Li F
Nanotechnology; 2021 Nov; 33(5):. PubMed ID: 34700307
[TBL] [Abstract][Full Text] [Related]
9. Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics.
Lin G; Mi P; Chu C; Zhang J; Liu G
Adv Sci (Weinh); 2016 Nov; 3(11):1600134. PubMed ID: 27980988
[TBL] [Abstract][Full Text] [Related]
10. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue.
Gote V; Nookala AR; Bolla PK; Pal D
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925129
[TBL] [Abstract][Full Text] [Related]
11. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
12. Recent Trends in Nanomedicine-Based Strategies to Overcome Multidrug Resistance in Tumors.
Khan MM; Torchilin VP
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077660
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnologies for the treatment of colon cancer: From old drugs to new hope.
Kotelevets L; Chastre E; Desmaële D; Couvreur P
Int J Pharm; 2016 Nov; 514(1):24-40. PubMed ID: 27863668
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance: Physiological principles and nanomedical solutions.
Kunjachan S; Rychlik B; Storm G; Kiessling F; Lammers T
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1852-1865. PubMed ID: 24120954
[TBL] [Abstract][Full Text] [Related]
15. Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress.
Ahmad J; Ameeduzzafar ; Ahmad MZ; Akhter H
Curr Pharm Des; 2020; 26(11):1181-1190. PubMed ID: 32056517
[TBL] [Abstract][Full Text] [Related]
16. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
17. Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview.
Alshememry AK; Alsaleh NB; Alkhudair N; Alzhrani R; Alshamsan A
Front Pharmacol; 2022; 13():933457. PubMed ID: 36091785
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic strategies to overcome taxane resistance in cancer.
Das T; Anand U; Pandey SK; Ashby CR; Assaraf YG; Chen ZS; Dey A
Drug Resist Updat; 2021 Mar; 55():100754. PubMed ID: 33691261
[TBL] [Abstract][Full Text] [Related]
19. Novel nanomedicines to overcome cancer multidrug resistance.
Su Z; Dong S; Zhao SC; Liu K; Tan Y; Jiang X; Assaraf YG; Qin B; Chen ZS; Zou C
Drug Resist Updat; 2021 Sep; 58():100777. PubMed ID: 34481195
[TBL] [Abstract][Full Text] [Related]
20. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology.
Xue X; Liang XJ
Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
